Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-13
2008-05-13
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S121000, C540S145000, C514S410000, C424S009362, C424S009610, C534S015000
Reexamination Certificate
active
07371742
ABSTRACT:
This invention relates to porphyrin compounds used to destroy or impair the functioning of a target biological material in photodynamic therapy, in particular against virus, tumoral cells, bacteria, tumorous tissues. The invention also relates to compositions containing such compounds and to a method in vitro to photosensitize detroy or impair the functioning of such target biological material.
REFERENCES:
patent: 2709491 (1995-03-01), None
patent: 2709491 (1995-03-01), None
Ahmad et al. Involve,emt of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431. Oncogene (1999) 18, pp. 1891-1896.
Berg et al. CAS registry and reference. Mitotic inhibition by phenylporphines and tetrasulfonated aluminum phthalocyanine in combination with light. Photochemistry and Photobiology (1992), 56(3) pp. 333-339.
Guo et al . CAS registry and reference. Synthesis of glycoconjugated metalloporphyrins and their selective catalysis for alkaqne oxidation under mild conditions. Huaxue Xuebao (2000) 58(3) pp. 332-337.
Pasetto et al. Synthesis of hydrolytically stable porphyrin C- and S-glycoconjugates in high yields. Chemical Communications (2001) pp. 81-82.
Zhang et al. Synthesis of acetylglycosylated metalloporphyrins and their catalysis for cyclohexane oxidation with PhlO under mild conditions. J. of Molecular Catalysis (2000) 154 pp. 31-38.
“Synthesis of hydrolytically stable porphyrin C-and S-glycoconjugates in high yields”, P. Pasetto, et al. Chem. Commun. (Cambridge), 2001, 81-82.
“Phytodynamic therapy of experimental introcular retinoblastomas-dose-response relationships to light energy and Photofrin II”, J. Winther, et al., Acta Ophthalmologica 1989, pp. 44-50.
Carrez Danielle
Croisy Alain
Figueiredo Telmo
Grierson David
Loock Bernard
Blakely & Sokoloff, Taylor & Zafman
Centre National de la Recherche Scientifique "CNRS"
Institut Curie
Ward Paul V.
Wilson James O.
LandOfFree
Porphyrin derivatives for photodynamic therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porphyrin derivatives for photodynamic therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porphyrin derivatives for photodynamic therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2799011